Similar articles for PMID: 28099785

Year	Number of Results
1994	3
1995	1
1996	1
1999	1
2000	2
2001	1
2002	4
2004	1
2005	1
2006	1
2008	1
2009	1
2010	4
2011	6
2012	3
2013	16
2014	12
2015	13
2016	13
2017	12
2018	4
2019	2
2020	1
2021	4
2022	1
2024	0

1

A Dual Topoisomerase Inhibitor of Intense Pro-Apoptotic and Antileukemic Nature for Cancer Treatment.

Meier C, Steinhauer TN, Koczian F, Plitzko B, Jarolim K, Girreser U, Braig S, Marko D, Vollmar AM, Clement B. Meier C, et al. ChemMedChem. 2017 Mar 7;12(5):347-352. doi: 10.1002/cmdc.201700026. Epub 2017 Feb 8. ChemMedChem. 2017. PMID: 28099785

2

The Novel Dual Topoisomerase Inhibitor P8-D6 Shows Anti-myeloma Activity In Vitro and In Vivo.

Klausz K, Kellner C, Gehlert CL, Krohn S, Wilcken H, Floerkemeier I, Günther A, Bauerschlag DO, Clement B, Gramatzki M, Peipp M. Klausz K, et al. Mol Cancer Ther. 2022 Jan;21(1):70-78. doi: 10.1158/1535-7163.MCT-21-0119. Epub 2021 Nov 1. Mol Cancer Ther. 2022. PMID: 34725192

3

A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.

Yu CC, Pan SL, Chao SW, Liu SP, Hsu JL, Yang YC, Li TK, Huang WJ, Guh JH. Yu CC, et al. Biochem Pharmacol. 2014 Aug 1;90(3):320-30. doi: 10.1016/j.bcp.2014.06.001. Epub 2014 Jun 7. Biochem Pharmacol. 2014. PMID: 24915421

4

4β-[4'-(1-(Aryl)ureido)benzamide]podophyllotoxins as DNA topoisomerase I and IIα inhibitors and apoptosis inducing agents.

Kamal A, Suresh P, Ramaiah MJ, Srinivasa Reddy T, Kapavarapu RK, Rao BN, Imthiajali S, Lakshminarayan Reddy T, Pushpavalli SN, Shankaraiah N, Pal-Bhadra M. Kamal A, et al. Bioorg Med Chem. 2013 Sep 1;21(17):5198-208. doi: 10.1016/j.bmc.2013.06.033. Epub 2013 Jun 21. Bioorg Med Chem. 2013. PMID: 23849207

5

Synthesis, cytotoxicity and topoisomerase inhibition properties of multifarious aminoalkylated indeno[1,2-c]isoquinolin-5,11-diones.

Ahn G, Schifano-Faux N, Goossens JF, Baldeyrou B, Couture A, Grandclaudon P, Lansiaux A, Ryckebusch A. Ahn G, et al. Bioorg Med Chem Lett. 2011 Apr 15;21(8):2259-63. doi: 10.1016/j.bmcl.2011.02.106. Epub 2011 Mar 1. Bioorg Med Chem Lett. 2011. PMID: 21439821

6

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents.

Cincinelli R, Musso L, Artali R, Guglielmi MB, La Porta I, Melito C, Colelli F, Cardile F, Signorino G, Fucci A, Frusciante M, Pisano C, Dallavalle S. Cincinelli R, et al. PLoS One. 2018 Oct 9;13(10):e0205018. doi: 10.1371/journal.pone.0205018. eCollection 2018. PLoS One. 2018. PMID: 30300374 Free PMC article.

7

F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103.

Etiévant C, Kruczynski A, Barret JM, Perrin D, van Hille B, Guminski Y, Hill BT. Etiévant C, et al. Cancer Chemother Pharmacol. 2000;46(2):101-13. doi: 10.1007/s002800000133. Cancer Chemother Pharmacol. 2000. PMID: 10972479

8

A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.

Karki R, Jun KY, Kadayat TM, Shin S, Thapa Magar TB, Bist G, Shrestha A, Na Y, Kwon Y, Lee ES. Karki R, et al. Eur J Med Chem. 2016 May 4;113:228-45. doi: 10.1016/j.ejmech.2016.02.050. Epub 2016 Feb 22. Eur J Med Chem. 2016. PMID: 26945111

9

Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.

Chaniyara R, Tala S, Chen CW, Zang X, Kakadiya R, Lin LF, Chen CH, Chien SI, Chou TC, Tsai TH, Lee TC, Shah A, Su TL. Chaniyara R, et al. J Med Chem. 2013 Feb 28;56(4):1544-63. doi: 10.1021/jm301788a. Epub 2013 Feb 14. J Med Chem. 2013. PMID: 23360284

10

Novel angular benzophenazines: dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents.

Vicker N, Burgess L, Chuckowree IS, Dodd R, Folkes AJ, Hardick DJ, Hancox TC, Miller W, Milton J, Sohal S, Wang S, Wren SP, Charlton PA, Dangerfield W, Liddle C, Mistry P, Stewart AJ, Denny WA. Vicker N, et al. J Med Chem. 2002 Jan 31;45(3):721-39. doi: 10.1021/jm010329a. J Med Chem. 2002. PMID: 11806724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year